Whittenburg stated, "We believe this transaction will achieve significant value for our shareholders and going forward enables us to expand our offerings as a leading provider of urological products and services. HealthTronics President and CEO James S.B. The transaction has been approved by the boards of directors of both companies.
Endo pharmaceuticals stock quote plus#
Under the terms of the merger agreement, Endo will commence an all cash tender offer to acquire all of the outstanding shares of HealthTronics common stock for approximately $223 million or $4.85 cash per HealthTronics share plus the assumption of debt. (Nasdaq: HTRN), a leading provider of urological products and services, today announced that it has signed a definitive merger agreement with Endo Pharmaceuticals (Nasdaq: ENDP) pursuant to which Endo will acquire HealthTronics. AUSTIN, Texas, May 5 /PRNewswire-FirstCall/ - HealthTronics, Inc.
0 kommentar(er)
